Skip to content
The Policy VaultThe Policy Vault

RetacritMedica

Anemia in a patient with human immunodeficiency virus who is receiving zidovudine

Initial criteria

  • Patient meets ONE of the following (A or B):
  • A) Initial Therapy. Approve if ALL of the following (i, ii, iii):
  • i. ONE of the following: a) hemoglobin < 10.0 g/dL; OR b) serum erythropoietin level ≤ 500 mU/mL; AND
  • ii. Patient is currently receiving zidovudine; AND
  • iii. ONE of the following: a) currently receiving iron therapy; OR b) has adequate iron stores per prescriber;
  • B) Patient currently receiving an erythropoiesis-stimulating agent and ALL of the following (i, ii, iii):
  • i. Hemoglobin ≤ 12.0 g/dL; AND
  • ii. Currently receiving zidovudine; AND
  • iii. ONE of the following: a) currently receiving iron therapy; OR b) has adequate iron stores per prescriber.

Approval duration

1 year